Dr. Richard Gallo, Co-Founder of MatriSys Bioscience, Honored by Leading Dermatology and Allergy Organizations

Matrisys Bioscience, a private, clinical-stage pharmaceutical company focused on developing live biotherapeutic products (LBPs) for chronic dermatologic indications, is proud to announce that its scientific co-founder, Dr. Richard Gallo, has been honored with the esteemed Eugene J Van Scott award for Innovative Therapy of the Skin from the American Academy of Dermatology (AAD).

To recognize this achievement, Dr. Gallo will be presenting the Philip Frost Leadership lecture during the AAD virtual conference plenary session on March 19th. This award was created in 2007 to acknowledge innovation in the treatment of skin diseases and conditions, and Matrisys Bioscience is proud to support Dr. Gallo’s pioneering work in the field.

At the annual meeting of the American Academy of Asthma, Allergy and Immunology (AAAAI) in San Antonio TX, Dr. Gallo was honored with the Michael M. Frank MD lecture, where he presented his research into the microbiome of the skin and its implications for patient care in atopic dermatitis and other chronic conditions. His findings offered new insights into the treatment of these conditions, providing a hopeful outlook for those affected.

About Dr. Richard Gallo

Dr. Richard L. Gallo MD PhD is a renowned Physician Scientist and Distinguished Professor and Chairman of Dermatology at the University of California San Diego. His pioneering work in the fields of innate immunity and the functions of the microbiome on the skin has received global recognition, transforming therapeutic approaches and redefining understanding of the pathophysiology of human diseases such as rosacea and atopic dermatitis.

Dr. Gallo is one of the most highly cited investigators in Medicine, and has over 400 publications to his name. He has been honoured by election to numerous prestigious societies such as the American Association for the Advancement of Science, American Society for Clinical Investigation, Association of American Physicians, American Society of Microbiology, and the American Dermatological Society.

Dr. Gallo is often invited to present his work at national and international meetings, and has achieved many awards for his contributions in Dermatology, Microbiology and Immunology.

About MatriSys BioScience

MatriSys Bioscience is revolutionizing the treatment of chronic dermatologic diseases in children and adolescents. Our groundbreaking technology platform identifies beneficial bacteria from human skin and develops these into treatments that offer a safe and effective alternative to traditional immunosuppressants and antibiotics. By harnessing the power of the human microbiome, we are bringing the promise of a healthier future to those who suffer from chronic skin conditions.

Leave a Comment